Privia Health Group (PRVA)
NASDAQ:PRVA
PRVA Stock Chart & Stats
$21.03
$0.26(1.28%)
At close: 4:00 PM EST
$21.03
$0.26(1.28%)
Day’s Range― - ―
52-Week Range$18.77 - $26.51
Previous CloseN/A
Volume48.95K
Average Volume (3M)869.22K
Market Cap
$2.54B
Enterprise Value-$467.61B
Total Cash (Recent Filing)$479.69B
Total Debt (Recent Filing)$9.53B
Price to Earnings (P/E)126.4
Beta0.70
Next Earnings
May 07, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding123,688,286
10 Day Avg. Volume870,649
30 Day Avg. Volume869,219
Financial Highlights & Ratios
PEG Ratio2.17
Price to Book (P/B)<0.01
Price to Sales (P/S)1.36
P/FCF Ratio17.86
Enterprise Value/Market Cap-184.06
Enterprise Value/Revenue-220.28
Enterprise Value/Gross Profit-2.32K
Enterprise Value/Ebitda-9.18K
Forecast
1Y Price Target
$31.85Price Target Upside51.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
EPS Forecast (FY)0.35
Revenue Forecast (FY)$2.38B
Bulls Say, Bears Say
Bulls Say
AI-driven Margin ExpansionManagement's deployment of artificial intelligence is positioned to materially improve operating margins and streamline clinical and administrative workflows, supporting sustained profitability gains.
Capital Strength And Cash GenerationA capital-efficient business model with strong free cash flow conversion and a substantial cash balance without debt provides flexibility to pursue strategic acquisitions and fund organic expansion to compound earnings.
Expansion Through AcquisitionsAcquisitions of ACOs and a managed care organization broaden the value-based care footprint and enable onboarding of physician groups that use diverse technology systems, creating new growth avenues.
Bears Say
Analyst Conflict-of-interest RiskDisclosed business relationships between the covering firm and researched companies create potential conflicts of interest that could undermine the perceived objectivity of analyst reports.
Practice Collections ShortfallManagement guidance indicating lower practice collections than analysts expect may constrain revenue growth and create headwinds for sales and revenue recognition.
Taxation And Cash Flow PressureA transition to full cash taxation combined with guidance for lower free cash flow conversion could limit near-term cash generation and reduce available capital for investments.
Privia Health Group News
PRVA FAQ
What was Privia Health Group’s price range in the past 12 months?
Privia Health Group lowest stock price was $18.77 and its highest was $26.51 in the past 12 months.
What is Privia Health Group’s market cap?
Privia Health Group’s market cap is $2.54B.
When is Privia Health Group’s upcoming earnings report date?
Privia Health Group’s upcoming earnings report date is May 07, 2026 which is in 41 days.
How were Privia Health Group’s earnings last quarter?
Privia Health Group released its earnings results on Feb 26, 2026. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.04.
Is Privia Health Group overvalued?
According to Wall Street analysts Privia Health Group’s price is currently Undervalued.
Does Privia Health Group pay dividends?
Privia Health Group does not currently pay dividends.
What is Privia Health Group’s EPS estimate?
Privia Health Group’s EPS estimate is 0.07.
How many shares outstanding does Privia Health Group have?
Privia Health Group has 123,688,286 shares outstanding.
What happened to Privia Health Group’s price movement after its last earnings report?
Privia Health Group reported an EPS of $0.07 in its last earnings report, beating expectations of $0.03. Following the earnings report the stock price went up 9.978%.
Which hedge fund is a major shareholder of Privia Health Group?
Currently, no hedge funds are holding shares in PRVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Privia Health Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$31.85 (51.45% Upside)
$31.85 (51.45% Upside)
Blogger Sentiment
Bullish
PRVA Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 397.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 4.1%
Last 30 Days ▲ 22.5%
Last 30 Days ▲ 22.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.08%
12-Months-Change
Fundamentals
Return on Equity
0.01%
Trailing 12-Months
Asset Growth
21.98%
Trailing 12-Months
Company Description
Privia Health Group
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
PRVA Company Deck
PRVA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a strongly positive operational and financial performance picture for 2025: robust provider and attributed lives growth, double-digit practice collections and care margin gains, significant adjusted EBITDA growth (38.8%), exceptional free cash flow generation in 2025, and a solid balance sheet (~$480M cash). Management provided constructive 2026 guidance (midpoint ~19.5% adjusted EBITDA growth, care margin up ~13%, and continued provider/lives expansion) while highlighting disciplined capital deployment and M&A (Evolent ACO acquisition adds ~120k lives). Key risks discussed include normalization of EBITDA-to-FCF conversion to ~80% due to becoming a cash taxpayer, quarter-to-quarter collections timing variability, payer/MA program uncertainty (REACH→LEAD), and integration/time risk for acquired ACO providers not yet on Privia’s platform. Overall, the positives—substantial growth, strong margins, high retention/NPS, and a strong cash position—outweigh the headwinds and execution risks mentioned.View all PRVA earnings summariesPRVA Stock 12 Month Forecast
Average Price Target
$31.85
▲(51.45% Upside)
Technical Analysis
Ownership Overview
2.11% Insiders
27.90% Mutual Funds
31.53% Other Institutional Investors
15.38% Public Companies and
Individual Investors